learning from experience
With over 200 completed studies we have invested many thousands of hours in the safe, ethical conduct of clinical trials. We specialize in conducting Phase II, III, and IV studies along side our partner sponsors. For site feasibility enquiries please visit out Contact Us page.
Spravato© is a prescription medicine, used with an antidepressant take by mouth, for Treatment Resistant Depression (TRD) in adults.
Transcranial Magnetic Stimulation is a non-invasive treatment for depression symptoms unresponsive to other treatments.
Leading the way in personalized medicine. Pharmacogenomics examines links between genetics and treatment.
Clinical research into treatments for Major Depressive Disorder and it’s associated symptoms.
Is your current medication not enough to treat your schizophrenia symptoms?
established in 2012, Chatham-Kent Clinical Trials Research Centre strives for excellence in patient care and professional practice.